Table 1 Number of patients available for analysis according to cancer site and time period from diagnosis of VTE to diagnosis of malignancy

From: Idiopathic venous thromboembolic disease is associated with a poorer prognosis from subsequent malignancy

 

Number of patients according to time period from diagnosis of VTE to diagnosis of malignancy

Cancer site

0–6 months

>6–12 months

>1–2 years

>2–5 years

No VTE in 0–5 years

Oesophagus

42

21

27

8

8,697

Stomach

143

20

38

20

13,247

Colon

307

43

81

29

25,801

Rectum

69

6

37

8

12,776

Pancreas

186

15

18

7

7,284

Lung

538

107

155

72

56,779

Breast

92

39

80

24

39,262

Cervix uteri

29

4

11

2

5,305

Corpus uteri

29

2

8

5

4,479

Ovary

177

10

19

11

7,115

Prostate

163

35

92

33

19,750

Kidney

72

6

21

8

5,453

Bladder

78

16

56

9

15,275

Non-Hodgkins lymphoma

121

12

21

12

9,117

Lymphoid leukaemia

35

10

13

4

3,532

All malignanciesa

2,710

425

871

316

299,714

  1. ICD=International Classification of Diseases; VTE=venous thromboembolism.
  2. aAll malignancies within range the ICD 10 C00-C96, excluding non-melanomatous skin cancer.
Back to article page